Literature DB >> 23820882

First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes.

Giovanni B Forleo1, Luigi Di Biase, Massimo Mantica, Germana Panattoni, Matteo Santamaria, Quintino Parisi, Domenico Sergi, Lida P Papavasileiou, Luca Santini, Claudio Tondo, Andrea Natale, Francesco Romeo.   

Abstract

PURPOSE: A new four-pole connector system (DF-4) for transvenous high-voltage implantable cardioverter defibrillators (ICD) is currently available in clinical practice. However, no clinical data demonstrating the safety and effectiveness of this complex electromechanical design is available. This study aims to test the safety and effectiveness of this newly designed system compared to the conventional DF-1 leads.
METHODS: During a 3-year period, 351 consecutive patients were implanted with DF-4 leads as part of an ICD or ICD-cardiac resynchronization therapy system. Patients were matched for age, sex, and follow-up with 154 patients implanted with a standard DF-1 lead. The primary outcome of the study was defibrillation lead failure, defined as the need for lead removal or capping. Operative, electrical, and safety data were obtained at implant and during postoperative follow-up.
RESULTS: Implantation success rate in both groups was 100 %. A trend towards shorter procedure time was observed in the DF-4 group but the difference did not reach statistical significance. Handling characteristics of the DF-4 leads were graded better than those of DF-1 models. During a total follow-up of 8,130.5 lead-months, there were nine ICD-lead failures (four system erosion/infections and five electrical lead dysfunctions). The overall incidence of electrical lead failure was 0.64 vs. 0.97 per 100 lead-years, for DF-4 and DF-1 leads, respectively (P = 0.2).
CONCLUSIONS: This multi-center experience provides strong evidence that the feasibility and safety of this novel technology compare favorably with those of the conventional DF-1 leads.

Entities:  

Mesh:

Year:  2013        PMID: 23820882     DOI: 10.1007/s10840-013-9814-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  15 in total

1.  Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.

Authors:  William H Maisel; Megan Moynahan; Bram D Zuckerman; Thomas P Gross; Oscar H Tovar; Donna-Bea Tillman; Daniel B Schultz
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes.

Authors:  Giovanni B Forleo; Domenico G Della Rocca; Lida P Papavasileiou; Arianna Di Molfetta; Luca Santini; Francesco Romeo
Journal:  Heart Rhythm       Date:  2010-09-29       Impact factor: 6.343

3.  Transvenous implantable cardioverter-defibrillator leads: the weakest link.

Authors:  William H Maisel
Journal:  Circulation       Date:  2007-05-15       Impact factor: 29.690

4.  Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

Authors:  William H Maisel; Robert G Hauser; Stephen C Hammill; Robert G Hauser; Kenneth A Ellenbogen; Andrew E Epstein; David L Hayes; Joseph S Alpert; Ronald D Berger; Anne B Curtis; Anne M Dubin; N A Mark Estes; Melanie T Gura; Andrew D Krahn; Rachel Lampert; Bruce D Lindsay; Bruce L Wilkoff
Journal:  Heart Rhythm       Date:  2009-06       Impact factor: 6.343

5.  Learning from our mistakes? Testing new ICD technology.

Authors:  Robert G Hauser; Adrian K Almquist
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

6.  Performance and survival of transvenous defibrillation leads: need for a European data registry.

Authors:  Andreas Goette; Francesco Cantu; Lieselot van Erven; Peter Geelen; Franck Halimi; Jose L Merino; John M Morgan
Journal:  Europace       Date:  2008-11-11       Impact factor: 5.214

7.  Implantable cardioverter-defibrillator lead performance.

Authors:  William H Maisel; Daniel B Kramer
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

8.  Risk of failure of transvenous implantable cardioverter-defibrillator leads.

Authors:  C Jan Willem Borleffs; Lieselot van Erven; Rutger J van Bommel; Enno T van der Velde; Ernst E van der Wall; Jeroen J Bax; Frits R Rosendaal; Martin J Schalij
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-04-17

9.  Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure?

Authors:  Renato Pietro Ricci; Carlo Pignalberi; Barbara Magris; Stefano Aquilani; Vito Altamura; Loredana Morichelli; Antonio Porfili; Laura Quarta; Fabio Saputo; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2011-09-01       Impact factor: 1.900

10.  Introduction of new industry standards for cardiac implantable electronic devices: balancing benefits and unexpected risks.

Authors:  Christian Sticherling; Haran Burri
Journal:  Europace       Date:  2012-03-01       Impact factor: 5.214

View more
  1 in total

Review 1.  [ICD leads].

Authors:  Carsten W Israel; Mohamed Karim Sheta
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.